Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome.

Hodges SL, Nolan SO, Tomac LA, Muhammad IDA, Binder MS, Taube JH, Lugo JN.

Physiol Behav. 2020 Mar 1;215:112776. doi: 10.1016/j.physbeh.2019.112776. Epub 2019 Dec 12.

PMID:
31838149
2.

Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells.

Lujan H, Griffin WC, Taube JH, Sayes CM.

Int J Nanomedicine. 2019 Jul 11;14:5159-5173. doi: 10.2147/IJN.S203330. eCollection 2019.

3.

GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.

Vijay GV, Zhao N, Den Hollander P, Toneff MJ, Joseph R, Pietila M, Taube JH, Sarkar TR, Ramirez-Pena E, Werden SJ, Shariati M, Gao R, Sobieski M, Stephan CC, Sphyris N, Miura N, Davies P, Chang JT, Soundararajan R, Rosen JM, Mani SA.

Breast Cancer Res. 2019 Mar 7;21(1):37. doi: 10.1186/s13058-019-1125-0.

4.

Total Synthesis and Anticancer Activity of (+)-Hypercalin C and Congeners.

Tao Y, Reisenauer K, Taube JH, Romo D.

Angew Chem Int Ed Engl. 2019 Feb 25;58(9):2734-2738. doi: 10.1002/anie.201812909. Epub 2019 Feb 1.

PMID:
30600887
5.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-6.

Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S.

Noncoding RNA. 2018 Sep 18;4(3). pii: E23. doi: 10.3390/ncrna4030023.

6.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-5.

Achour C, Bogard B, Hubé F, Mani SA, Santulli G, Taube JH.

Noncoding RNA. 2017 Jun 14;3(2). pii: E21. doi: 10.3390/ncrna3020021.

7.

The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition.

Taube JH, Sphyris N, Johnson KS, Reisenauer KN, Nesbit TA, Joseph R, Vijay GV, Sarkar TR, Bhangre NA, Song JJ, Chang JT, Lee MG, Soundararajan R, Mani SA.

Oncotarget. 2017 Jul 10;8(39):65548-65565. doi: 10.18632/oncotarget.19214. eCollection 2017 Sep 12.

8.

Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-α expression.

Hodges SL, Nolan SO, Taube JH, Lugo JN.

Neuroreport. 2017 Dec 13;28(18):1246-1249. doi: 10.1097/WNR.0000000000000905.

9.

Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9.

Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB.

Noncoding RNA. 2016 Sep 30;2(4). pii: E10. doi: 10.3390/ncrna2040010.

10.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-4.

Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB.

Noncoding RNA. 2016 Sep 21;2(3). pii: E9. doi: 10.3390/ncrna2030009. Erratum in: Noncoding RNA. 2016 Sep 30;2(4):.

11.

Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.

Werden SJ, Sphyris N, Sarkar TR, Paranjape AN, LaBaff AM, Taube JH, Hollier BG, Ramirez-Peña EQ, Soundararajan R, den Hollander P, Powell E, Echeverria GV, Miura N, Chang JT, Piwnica-Worms H, Rosen JM, Mani SA.

Oncogene. 2016 Nov 17;35(46):5977-5988. doi: 10.1038/onc.2016.203. Epub 2016 Jun 13.

12.

Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia.

Dhawan A, Madani Tonekaboni SA, Taube JH, Hu S, Sphyris N, Mani SA, Kohandel M.

Sci Rep. 2016 Feb 3;6:18074. doi: 10.1038/srep18074.

13.

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, Maity SN, Logothetis C, Tang DG, Mani SA.

Oncogene. 2016 Nov 17;35(46):5963-5976. doi: 10.1038/onc.2015.498. Epub 2016 Jan 25.

14.

GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.

Sarkar TR, Battula VL, Werden SJ, Vijay GV, Ramirez-Peña EQ, Taube JH, Chang JT, Miura N, Porter W, Sphyris N, Andreeff M, Mani SA.

Oncogene. 2015 Jun 4;34(23):2958-67. doi: 10.1038/onc.2014.245. Epub 2014 Aug 11.

15.

Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition.

Malouf GG, Taube JH, Lu Y, Roysarkar T, Panjarian S, Estecio MR, Jelinek J, Yamazaki J, Raynal NJ, Long H, Tahara T, Tinnirello A, Ramachandran P, Zhang XY, Liang S, Mani SA, Issa JP.

Genome Biol. 2013 Dec 24;14(12):R144. doi: 10.1186/gb-2013-14-12-r144.

16.

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.

Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML.

Breast Cancer Res Treat. 2014 Jan;143(1):189-201. doi: 10.1007/s10549-013-2796-3. Epub 2013 Dec 4.

17.

Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.

Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SA.

Sci Rep. 2013;3:2687. doi: 10.1038/srep02687.

18.

Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.

Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M.

PLoS One. 2013 May 29;8(5):e64169. doi: 10.1371/journal.pone.0064169. Print 2013.

19.

FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.

Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, Mani SA.

Cancer Res. 2013 Mar 15;73(6):1981-92. doi: 10.1158/0008-5472.CAN-12-2962. Epub 2013 Feb 1.

20.

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.

Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, Mani SA.

Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54. doi: 10.1073/pnas.1004900107. Epub 2010 Aug 16. Erratum in: Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19132.

21.

Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells.

Taube JH, Allton K, Duncan SA, Shen L, Barton MC.

J Biol Chem. 2010 May 21;285(21):16135-44. doi: 10.1074/jbc.M109.088096. Epub 2010 Mar 26.

22.

Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.

Cui R, Nguyen TT, Taube JH, Stratton SA, Feuerman MH, Barton MC.

J Biol Chem. 2005 Nov 25;280(47):39152-60. Epub 2005 Oct 2.

Supplemental Content

Loading ...
Support Center